ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 110 filers reported holding ATHIRA PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,671 | -41.5% | 9,738 | -14.6% | 0.00% | -50.0% |
| Q2 2023 | $33,651 | +18.0% | 11,407 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $28,518 | -21.1% | 11,407 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $36,160 | -27.7% | 11,407 | -32.6% | 0.00% | -50.0% |
| Q3 2022 | $50,000 | -29.6% | 16,920 | -27.8% | 0.01% | -33.3% |
| Q2 2022 | $71,000 | -78.2% | 23,420 | -3.1% | 0.01% | -76.0% |
| Q1 2022 | $326,000 | +7.6% | 24,173 | +4.1% | 0.05% | +8.7% |
| Q4 2021 | $303,000 | +114.9% | 23,220 | +54.5% | 0.05% | +24.3% |
| Q3 2021 | $141,000 | -65.7% | 15,031 | -62.6% | 0.04% | -59.8% |
| Q2 2021 | $411,000 | -10.5% | 40,139 | +61.0% | 0.09% | -10.7% |
| Q1 2021 | $459,000 | -50.4% | 24,927 | -7.8% | 0.10% | -54.4% |
| Q4 2020 | $926,000 | +221.5% | 27,027 | +73.5% | 0.23% | +186.1% |
| Q3 2020 | $288,000 | – | 15,575 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 714,763 | $2,265,799 | 2.16% |
| Perceptive Advisors | 4,797,278 | $15,207,371 | 0.43% |
| Potomac Capital Management, Inc. | 80,000 | $254 | 0.30% |
| Bristlecone Advisors, LLC | 696,629 | $2,208,314 | 0.27% |
| TANG CAPITAL MANAGEMENT LLC | 485,234 | $1,538,192 | 0.22% |
| RA Capital Management | 1,881,300 | $5,963,721 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 270,989 | $859 | 0.11% |
| PATHSTONE FAMILY OFFICE, LLC | 3,631,080 | $8,182,650 | 0.07% |
| Laird Norton Wetherby Trust Company, LLC | 130,000 | $412,100 | 0.06% |
| Forefront Analytics, LLC | 22,350 | $70,851 | 0.04% |